Published in

Wiley, Angewandte Chemie, 35(127), p. 10368-10371

DOI: 10.1002/ange.201503048

Wiley, Angewandte Chemie International Edition, 35(54), p. 10230-10233

DOI: 10.1002/anie.201503048

Links

Tools

Export citation

Search in Google Scholar

Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides

Journal article published in 2015 by Yong Wang, Pascal Pigeon ORCID, Siden Top, Michael J. McGlinchey, Gérard Jaouen
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The synthesis and chemical oxidation profile of a new generation of ferrocifen derivatives with strong anti-proliferative behavior in vitro is reported. In particular, the hydroxypropyl derivative HO(CH2)(3)C(Fc)= C(C6H4OH)(2) (3b) exhibited exceptional antiproliferative activity against the cancer cell lines HepG2 and MDA-MB-231 TNBC, with IC50 values of 0.07 and 0.11 mu m, respectively. Chemical oxidation of 3b yielded an unprecedented tetrahydrofuran-substituted quinone methide (QM) via internal cyclization of the hydroxyalkyl chain, whereas the corresponding alkyl analogue CH3CH2-C(Fc)= C(C6H4OH)(2) merely formed a vinyl QM. The ferrocenyl group in 3b plays a key role, not only as an intramolecular reversible redox ``antenna'', but also as a stabilized carbenium ion ``modulator''. The presence of the oxygen heterocycle in 3b-QM enhances its stability and leads to a unique chemical oxidation profile, thus revealing crucial clues for deciphering its mechanism of action in vivo.